【24h】

Elective stent-graft treatment of aortic dissections.

机译:选择性支架移植治疗主动脉夹层。

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: To retrospectively review 8 years' experience with stent-graft treatment of aortic dissections at a single institution.Methods: Forty-six patients (31 men; mean age 59 years, range 38-88) underwent stent-graft treatment for 9 Stanford type A and 37 type B aortic dissections (9 acute phase, 13 subacute, 24 chronic). Custom-designed self-expanding stainless steel Z stents covered with polytetrafluoroethylene were used (n=20) until low-profile modular stent-grafts became available for percutaneous delivery (n=26).Results: Endovascular stent-graft deployment was technically successful in 44 (96%) patients; the 2 failed cases owing to intraprocedural migration and graft torsion were converted to surgery. There were 5 type I endoleaks for a clinical success (entry tear exclusion) of 85% (39/46). Complications included 3 cases of transient renal failure, 2 puncture site pseudoaneurysms, 1 guidewire-induced new intimal tear (converted), and 2 cases of stent-induced saccular aneurysms (1 converted). Follow-up at a mean 34 months (range 12-96) showed complete resolution of the thoracic false lumen in 14 (74%) of 19 acute/subacute patients treated successfully; 3 (16%) showed a reduced thoracic false lumen diameter. In the 23 chronic-phase patients treated successfully, 8 (35%) had complete resolution of the thoracic false lumen, and 11 (48%) showed size reduction. Enlargement of the abdominal aortic false lumen due to persistent flow into re-entry tear(s) occurred in 3 (13%).Conclusions: Stent-graft treatment is a feasible and effective treatment modality in aortic dissection. However, close follow-up is mandatory to monitor new intimal tear, saccular aneurysms, or enlargement of the abdominal aortic false lumen.
机译:目的:回顾回顾在一家机构中8年的支架植入治疗主动脉夹层的经验。方法:46例患者(31男性;平均年龄59岁,年龄38-88)接受了9斯坦福大学的支架植入治疗。 A型和37型B型主动脉夹层(9个急性期,13个亚急性期,24个慢性期)。使用定制设计的自膨胀不锈钢Z支架(覆盖聚四氟乙烯)(n = 20),直到低矮的模块化模块化移植物可用于经皮输送(n = 26)为止。结果:在技术上成功地将血管内支架植入物成功应用于44名(96%)患者; 2例因术中移行和移植物扭转而失败的病例转为手术。 I型内漏有5种,其临床成功率(排除眼泪)为85%(39/46)。并发症包括3例短暂性肾功能衰竭,2例穿刺点假性动脉瘤,1根导线引起的新内膜撕裂(转化)和2例由支架引起的囊状动脉瘤(1例转化)。平均34个月(范围12-96)的随访结果显示,成功治疗的19例急性/亚急性患者中有14例(74%)完全消除了胸腔假腔。 3例(16%)的胸假管腔直径减小。在成功治疗的23例慢性期患者中,有8例(35%)完全消除了胸腔假腔,而11例(48%)出现了尺寸缩小。持续流入再入泪液导致腹主动脉假管腔扩大的比例为3(13%)。结论:支架置入术治疗是主动脉夹层的一种可行且有效的治疗方式。但是,必须密切随访以监测新的内膜撕裂,囊状动脉瘤或腹主动脉假管腔的扩大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号